Roivant Sciences Ltd (ROIV)
Sector: | Health Care |
Super Investor Stats: | |
Ownership count: | 1 |
Ownership rank: | 687 |
% of all portfolios: | 0.036% |
| |
Total insider Buys/Sells last 6 months: |
| Transactions | Total |
Buys |
0 |
$0 |
Sells |
2 |
$34,208,694 |
|
Portfolio Manager |
% of portfolio |
Recent activity |
Shares |
Value |
≡ |
Viking Global Investors |
2.86 |
Reduce 5.54% |
69,368,961 |
779,013,000 |
Open Market Insider Buys
Date Filed |
Reporting Name |
Relationship |
Trans. Date |
Shares |
Price $ |
Total Value $ |
14 Nov 2022 |
DEXCEL PHARMA TECHNOLOGIES LTD. |
10% |
10 Nov 2022 |
4,000,000 |
5.00 |
20,000,000 |
26 Apr 2022 |
DEXCEL PHARMA TECHNOLOGIES LTD. |
10% |
25 Apr 2022 |
8,600 |
3.91 |
33,635 |
26 Apr 2022 |
DEXCEL PHARMA TECHNOLOGIES LTD. |
10% |
22 Apr 2022 |
31,685 |
3.83 |
121,319 |
* "Hold Price" is the last known price at which an investor still held a security. It is the closing price of the security as of the portfolio date (quarter end). This value is only provided when a security is owned by at least two investors. In the case of reporting dates being different, a weighted average price is calculated.
P = Preferred Stock